Computational Design of Highly Selective Antimicrobial Peptides
暂无分享,去创建一个
Davor Juretic | Damir Vukicevic | Alessandro Tossi | Nada Ilic | Nikolinka Antcheva | A. Tossi | D. Juretic | N. Ilić | N. Antcheva | D. Vukičević
[1] Alessandro Tossi,et al. Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. , 2005, The Biochemical journal.
[2] Alessandro Tossi,et al. Amphipathic, α‐helical antimicrobial peptides , 2000 .
[3] P. Nicolas,et al. Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain. , 2003, European journal of biochemistry.
[4] Mikael Bodén,et al. Predicting the solvent accessibility of transmembrane residues from protein sequence. , 2006, Journal of proteome research.
[5] Frances Separovic,et al. Host defense peptides from the secretion of the skin glands of frogs: membrane-active peptides from the genera Litoria, Uperoleia and Crinia , 2009 .
[6] Michael Bienert,et al. Optimization of the antimicrobial activity of magainin peptides by modification of charge , 2001, FEBS letters.
[7] D. Eisenberg,et al. Hydrophobic moments and protein structure , 1982 .
[8] Michael R. Yeaman,et al. Unifying themes in host defence effector polypeptides , 2007, Nature Reviews Microbiology.
[9] J. Conlon,et al. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2 , 2005, Regulatory Peptides.
[10] Yiannis N. Kaznessis,et al. Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: Predicting experimental toxicity , 2008, Peptides.
[11] Jean-Marie Pagès,et al. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. , 2007, The Journal of antimicrobial chemotherapy.
[12] M. Gerstein,et al. Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions. , 2000, Journal of molecular biology.
[13] G M Anantharamaiah,et al. Molecular basis for prokaryotic specificity of magainin-induced lysis. , 1995, Biochemistry.
[14] P. F. Nielsen,et al. The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. , 2004, Biochemical and biophysical research communications.
[15] H V Westerhoff,et al. Magainins and the disruption of membrane-linked free-energy transduction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Barra,et al. Antimicrobial peptides from amphibian skin: what do they tell us? , 1998, Biopolymers.
[17] Robert E W Hancock,et al. Comparison of Biophysical and Biologic Properties of α‐Helical Enantiomeric Antimicrobial Peptides , 2006, Chemical biology & drug design.
[18] M. Michael Gromiha,et al. A Statistical Model for Predicting Protein Folding Rates from Amino Acid Sequence with Structural Class Information , 2005, J. Chem. Inf. Model..
[19] L. Llewellyn,et al. Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance , 2004, Peptides.
[20] Alessandro Tossi,et al. Amphipathic α helical antimicrobial peptides. , 2001 .
[21] A. Tossi,et al. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. , 1997, European journal of biochemistry.
[22] Y H Chen,et al. Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. , 1974, Biochemistry.
[23] Katsumi Matsuzaki,et al. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity. , 2002, Biochemistry.
[24] W. J. Waddell,et al. A simple ultraviolet spectrophotometric method for the determination of protein. , 1956, The Journal of laboratory and clinical medicine.
[25] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[26] T. Falla,et al. Host defense peptides for use as potential therapeutics. , 2009, Current opinion in investigational drugs.
[27] R. Hancock,et al. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. , 2006, Current opinion in pharmacology.
[28] H. Guy. Amino acid side-chain partition energies and distribution of residues in soluble proteins. , 1985, Biophysical journal.
[29] Nenad Trinajstić,et al. Protein transmembrane structure: recognition and prediction by using hydrophobicity scales through preference functions , 1998 .
[30] R. Hodges,et al. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α‐helical cationic antimicrobial peptides , 2009, Advances in experimental medicine and biology.
[31] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[32] F. Knoop,et al. Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog. , 2001, Biochemical and biophysical research communications.